CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


No intervention - exposure is to COVID-19Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug2262 Simultaneous EGD and colonoscopy Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Neonatal Complications of Coronavirus Disease (COVID-19)

There is an evidence gap in relation to the incidence, impact and severity of COVID-19 in newborn babies. International data are very limited, we have no robust estimates of incidence and no UK-based data with which to inform policy, clinical care, service delivery or advice to pregnant women. The research aims are to investigate the three mains ways in which COVID-19 might affect newborns and babies that need neonatal care: 1. Newborn babies might catch COVID-19 before, during or soon after birth and this may lead to problems with breathing or feeding that need support in hospital. 2. COVID-19 could affect babies that are already on neonatal units with other medical conditions (like being very premature) that place them at greater risk of severe COVID-19. 3. COVID-19 might affect that way that pregnant women are looked after in pregnancy, labour or bith which could lead to problems for some babies, even if they do not themselves become infected with COVID-19.

NCT04386109 Neonatal COVID-19 Disease Other: No intervention - exposure is to COVID-19
MeSH:Coronavirus Infections

Primary Outcomes

Description: Number of neonatal participants with COVID-19 divided by the total number of live births in the population

Measure: Incidence of neonatal COVID-19

Time: April 2020 to March 2021

Description: Number of neonatal participants with COVID-19 following vertically transmission of the Coronavirus divided by the total number of live births in the population

Measure: Incidence of vertically transmitted COVID-19

Time: April 2020 to March 2021

Secondary Outcomes

Description: Questionnaire data

Measure: Presentation and natural history of neonatal COVID-19

Time: April 2020 to March 2021

Description: Questionnaire data

Measure: Presentation of neonates with COVID-19 positive mothers

Time: April 2020 to March 2021

Description: Proportion of neonate participants who died and the proportion who were discharged home alive.

Measure: Outcomes for neonates with COVID-19

Time: April 2020 to March 2021

Description: Questionnaire data

Measure: Clinical treatment of neonatal COVID-19

Time: April 2020 to March 2021

Description: Questionnaire data

Measure: Neonatal secondary impacts of maternal COVID-19

Time: April 2020 to March 2021


No related HPO nodes (Using clinical trials)